DJIA 17,039.49 60.36 0.36%
NASDAQ 4,532.10 5.62 0.12%
S&P 500 1,992.37 5.86 0.29%
market minute promo

59.02 -0.45 (-0.76%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CRL $59.02 -0.76%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $59.50
Previous Close $59.47
Daily Range $58.75 - $59.68
52-Week Range $44.12 - $62.50
Market Cap $2.8B
P/E Ratio 24.08
Dividend (Yield) $0.00 (0.0%)
Volume 301,752
Average Daily Volume 459,330
Current FY EPS $3.32

Sector

Healthcare

Industry

Drugs

Charles River Laboratories (CRL) Description

Charles River supports early-stage drug development with a “research models” business that breeds lab rats and “preclinical services” that run clinical trials for pharma and biotech companies. Website: http://www.criver.com/

News & Commentary Rss Feed

Charles River Laboratories International Beats Analyst Estimates on EPS

Just the facts, Fool.

Update: Charles River Labs Earnings

Why Charles River Laboratories International (CRL) Could Beat Earnings Estimates Again - Tale of the

Why Charles River Laboratories International (CRL) Could Beat Earnings Estimates Again - Tale of the Tape

Insider Trading Alert - CRL, GLW And RVBD Traded By Insiders

Jim Cramer's Top Stock Picks: TSLA TNET CRL

3 Health Services Stocks Driving The Industry Higher

Air Methods (AIRM) Surges: Stock Adds 12.5% in Session - Tale of the Tape

Air Methods (AIRM) Surges: Stock Adds 12.5% in Session - Tale of the Tape

Parexel - Best CRO, But Wait For A Better Moment

Charles River Laboratories (CRL) Jumps: Stock Moves 5% Higher - Tale of the Tape

Charles River Laboratories International's (CRL) CEO James Foster on Q2 2014 Results - Earnings Call

Charles River Laboratories International's (CRL) CEO James Foster on Q2 2014 Results - Earnings Call Transcript

Charles River Beats on Q2 Earnings & Revenues, Outlook Upped - Analyst Blog

See More CRL News...

CRL's Top Competitors

CRL $59.02 (-0.76%)
Current stock: CRL
TMO $121.81 (-0.37%)
Current stock: TMO
ILMN $172.09 (-0.50%)
Current stock: ILMN
WAT $103.30 (-0.02%)
Current stock: WAT